Abstract:BACKGROUND:Microtia is a prevalent congenital malformation, the precise etiology and pathogenesis of which remain elusive. Mutations in the non-coding region of the HMX1 gene have been implicated in isolated cases of microtia, emerging as a significant focus of contemporary research. Several pathogenic copy number variations (CNVs) proximal to the HMX1 gene have been documented in wild animal populations, whereas only a single large segmental duplication in this region has been identified in humans. However, the absence of a gene-edited animal model has impeded the investigation of the unclear gene function associated with HMX1 mutations in human isolated microtia. In this study, we sought to precisely identify the pathogenic mutation by analyzing three pedigrees alongside population controls. Subsequently, our objective was to develop a CRISPR/Cas9 gene-edited mouse model to elucidate the functional implications of the identified mutation. METHODS:Genomic DNA was collected from 32 affected individuals across three pedigrees, as well as from 2000 control subjects. Comprehensive genomic analyses, including genome-wide linkage analysis, targeted capture, second-generation sequencing, and copy number analysis, were conducted to identify potential mutations associated with congenital auricle malformation. CRISPR/Cas9 gene-edited murine models were generated in response to the identified mutation. The auricular phenotypes of these gene-edited mice were systematically monitored. Small-animal Micro-CT scanning was employed to identify potential craniofacial or skeletal abnormalities. Furthermore, the expression of the HMX1 gene in the PA2 region of mouse embryos was quantified using RT-qPCR. RESULTS:A co-segregated 600 base pair duplication located on chromosome 4 (chr4:8701900-8702500, hg19) was identified in affected individuals across three pedigrees, but was absent in healthy controls. Two types of CRISPR/Cas9 gene-edited mice were subsequently generated. The knock-in (KI) mouse model was engineered by inserting one copy of the duplicated sequence directly adjacent to the mutated site, whereas the knockout (KO) mouse model was created by excising the mutation sequence. The phenotypes of different group of CRISPR/Cas9 gene-edited mice demonstrated distinct auricular deformities. Furthermore, an increase in the copy number of the mutated sequence was associated with elevated expression levels of HMX1 in the gene-edited mouse model. CONCLUSIONS:In this study, we further narrowed down and identified a 600 base pair copy number variation (CNV) located at chr4:8701900-8702500 (hg19), which is implicated in human bilateral, isolated microtia. Utilizing CRISPR/Cas9 technology, we developed novel mouse models harboring the identified mutation. These models serve as a robust platform for the comprehensive investigation of the underlying mechanisms of the disease.

An Innovative CRISPR/Cas9 Mouse Model of Human Isolated Microtia Indicates the Potential Contribution of CNVs Near HMX1 Gene

CRISPR/Cas9 Targeting Events Cause Complex Deletions and Insertions at 17 Sites in the Mouse Genome

Understanding the molecular mechanisms of human microtia via a pig model of HOXA1 syndrome.

Whole Genome Sequencing Analysis of Four Patients: Are De Novo Copy Number Variations in Non-Coding Region Responsible for Microtia with Lung Hypoplasia?

Genome-Wide Linkage Study Suggests A Susceptibility Locus for Isolated Bilateral Microtia on 4P15.32-4P16.2

Whole-Exome Sequencing of Discordant Monozygotic Twin Families for Identification of Candidate Genes for Microtia-Atresia

Genetic Analysis and Functional Assessment of a Variant in Micrognathia and Cleft Palate

Mutational Analysis of GSC, HOXA2 and PRKRA in 106 Chinese Patients with Microtia

Microrna Expression Profiling and Target Genes Study in Congenital Microtia

Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia

Mycn deficiency underlies the development of orofacial clefts in mice and humans

Genetic Analysis and Functional Assessment of a TGFBR2 Variant in Micrognathia and Cleft Palate

Efficient introduction of an isogenic homozygous mutation to induced pluripotent stem cells from a hereditary hearing loss family using CRISPR/Cas9 and single-stranded donor oligonucleotides

Key Genes Identified in Nonsyndromic Microtia by the Analysis of Transcriptomics and Proteomics

Genetic Screening of Targeted Region on the Chromosome 22q11.2 in Patients with Microtia and Congenital Heart Defect

A Humanized Murine Model, Demonstrating Dominant Progressive Hearing Loss Caused by a Novel KCNQ4 Mutation (p.g228d) from a Large Chinese Family

Identification of Key Genes and Signaling Pathways in Microtia by the Analysis of Transcriptomics

Identification of sequence variants associated with severe microtia-astresia by targeted sequencing

JAG2: A Potential Biomarker for Microtia Identified by Integrated RNA Transcriptome Analysis

A 76-Base Pair Duplication Within the Enhancer Region of the HMX1 Gene Causes Sheep Microtia.

Profiling of Long Non-Coding RNAs in Auricular Cartilage of Patients with Isolated Microtia.